Pricing Regime Drug Exclusion Leads to Suit

Published October 9, 2013

Pricing Regime Drug Exclusion Leads to Suit

Filed under: outpatient drug treatment programs

(CN) – The federal government illegally excluded drugs for rare diseases and conditions from a new rule setting maximum prices for medicines sold to certain treatment facilities, the pharmaceutical industry claims in court. In a lawsuit filed in the …
Read more on Courthouse News Service

AcelRx Pharmaceuticals Provides Update on its Patent Portfolio for Zalviso(TM …

Filed under: outpatient drug treatment programs

U.S. patent #8,357,114 entitled "Drug dispensing device with flexible push rod" relates to devices for dispensing a sublingual drug dosage form to a patient through a curved passage using a flexible rod to push a tablet. Issued January 22, 2013, with …
Read more on Wall Street Journal